UK NICE Changes Mind On Ocrevus After Roche Drops Price

 
• By Neena Brizmohun
  
healthcare-costs
NICE says Ocrevus is now a cost-effective use of NHS resources for PPMS • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Health Technology Assessment

More from Market Access